Health Final Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed Against AbbVie, Inc. (ABBV) June 5, 2022
Biotechnology Positive Phase 1 Data from mRNA-based Individualized Neoantigen Specific Immunotherapy in Patients with Resected Pancreatic Cancer presented at ASCO June 5, 2022
Health NEW HEAD-TO-HEAD DATA SHOW VECTIBIX® (PANITUMUMAB) DEMONSTRATED SUPERIOR OVERALL SURVIVAL COMPARED TO BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN JAPANESE PATIENTS WITH WILD-TYPE RAS COLORECTAL CANCER June 5, 2022
Health Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. (ABBV) Investors with Substantial Losses to Contact the Firm June 4, 2022
Health Everest Medicines’ Licensing Partner Gilead Sciences Announces Positive Results from Phase 3 TROPiCS-02 Study of Trodelvy® in Heavily Pre-treated HR+/HER2- Metastatic Breast Cancer Patients June 4, 2022
Biotechnology Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Oscar Health, Axsome, Humbl, and Okta and Encourages Investors to Contact the Firm June 3, 2022
Tech SHAREHOLDER ALERT: Weiss Law Reminds VEC, LLNW, VMW, and EBS Shareholders About Its Ongoing Investigations June 3, 2022
Search
Health
